Related Experiment Video
Updated: Jun 19, 2026
09:32
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Non-canonical peptides bound to MHC
Stephanie L Day1, Paul A Ramsland, Vasso Apostolopoulos
1Macfarlane Burnet Institute for Medical Research, Centre for Immunology, Immunology and Vaccine, and Structural Immunology Laboratories, VIC, Australia.
Current Pharmaceutical Design
|October 29, 2009
Summary
Understanding how T cell receptors (TCRs) recognize peptide-MHC complexes is key for developing effective peptide vaccines. This study emphasizes non-canonical bound peptides for immunotherapy research.
Area of Science:
- Immunology
- Molecular Biology
- Vaccine Development
Background:
- T cell-dependent immune responses are initiated by T cell receptors (TCRs) recognizing peptide-Major Histocompatibility Complex (pMHC) complexes.
- Specificity of TCRs for particular pMHC complexes ensures focused immune responses against specific antigens.
- Major Histocompatibility Complex molecules are termed Human Leukocyte Antigen (HLA) in humans and H-2 in mice.
Purpose of the Study:
- To provide a comprehensive understanding of the interactions between MHC molecules and peptides.
- To elucidate the mechanisms of TCR recognition of MHC/peptide complexes.
- To explore the potential of non-canonical bound peptides in immunotherapy.
Main Methods:
- Analysis of peptide-MHC interactions.
- TCR recognition studies.
- Investigation of non-canonical peptide binding to MHC molecules.
Main Results:
- Detailed characterization of peptide binding to MHC class I and class II molecules.
- Insights into TCR specificity for diverse pMHC structures.
- Demonstration of the utility of non-canonical peptides in immunotherapy models.
Conclusions:
- A thorough understanding of pMHC-TCR interactions is crucial for designing effective peptide-based vaccines.
- Non-canonical bound peptides represent a promising avenue for novel immunotherapy strategies.
- Further research into these interactions can advance the field of immunotherapeutics.
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:31Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:31Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...